Chugai Pharmaceutical Co. Ltd.

05/10/2021 | Press release | Distributed by Public on 05/10/2021 00:01

Chugai Reached Agreement with Japanese Government regarding Investigational Antibody Cocktail (casirivimab and imdevimab) for COVID-19